Advertisement

Payer

Advertisement

Humana is right behind the federal government in suing Regeneron for allegedly inflating its macular degeneration drug, Eylea, and using a "sham" charity to pay out kickbacks to cover cost-sharing obligations, according to the lawsuit. 

Humana released its second-quarter earnings results July 28 on the tails of payers still reporting a dropoff in profits. 

"You can't assume that you actually know the struggles that your members face," Healthfirst CEO Pat Wang shared with Becker's July 26. "I think intellectually, we were aware of the food insecurity and other social determinants of health challenges that…

Advertisement